MIR548S

Across TCGA pan-cancer cohorts, MIR548S RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR548S data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher MIR548S RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR548S expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

KICH, CHOL, and STAD are the cancer types where MIR548S RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	II,III,IV	0.479	0.912	.010	81	view →
CHOL	DFS	Tertile	II,III,IV	0.016	0.406	<.001	72	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	62	view →
DLBC	OS	Tertile	All	0.586	0.951	<.001	57	view →
HNSC	OS	Tertile	III,IV	0.394	0.751	.011	48	view →
LIHC	DFS	Tertile	II,III,IV	0.063	0.429	<.001	45	view →
THCA	DFS	Tertile	III,IV	0.732	0.902	.018	21	view →
MESO	OS	Tertile	III,IV	0.305	0.588	.035	18	view →
COAD	OS	Tertile	IV	0.045	0.659	<.001	18	view →
LUAD	DFS	Tertile	All	0.969	0.794	.007	15	view →
BRCA	OS	Tertile	All	0.919	0.965	.042	6	view →
UCEC	DFS	Tertile	All	0.712	0.843	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MIR548S–KICH (DFS)

Open the KICH breakdown →